MedTrace Logo

Venous Disease Thromboembolic and Amyotrophic Lateral Sclerosis

NCT04446325 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 227

Last updated 2020-09-11

No results posted yet for this study

Summary

Venous thrombo-embolic (VTE) rates could be high in patients with amyotrophic lateral sclerosis (ALS). Indeed, the rate of VTE in this specific population could be 7-fold higher in this population. Predictiv factors of VTE in patients with ALS are mobility reduction and neurological paralysis. However, to our knowledge, medical littérature is poor concerning VTE and ALS association.

Our first aim is to define annual rate of VTE in ALS population.Then we aim to identify predictiv factors of VTE in this specific population. The studied population is Brest universitary hospital cohort of ALS patient included between 2000 and 2019.

Conditions

  • Lateral Amyotrophic Sclerosis
  • Venous Thrombo-embolic Desease

Sponsors & Collaborators

  • University Hospital, Brest

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-03-01
Primary Completion
2020-03-01
Completion
2020-05-01

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04446325 on ClinicalTrials.gov